Characterization of PMP22 expression in osteosarcoma
- 15 July 2004
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 152 (2) , 113-118
- https://doi.org/10.1016/j.cancergencyto.2003.11.003
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Overexpression through amplification of genes in chromosome region 17p11.2∼p12 in high-grade osteosarcomaCancer Genetics and Cytogenetics, 2004
- Infrequent but high-level amplification of 17p11.2∼p12 in human gliomaCancer Genetics and Cytogenetics, 2003
- Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studiesJournal of Neuroscience Research, 2002
- Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell linesJournal of Neuroscience Research, 1999
- Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22 Trembler on cell growth of NIH3T3 fibroblastsCell and tissue research, 1997
- SR13/PMP‐22 expression in rat nervous system, in PC12 cells, and C6 glial cell linesJournal of Neuroscience Research, 1994
- Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelinationJournal of Neuroscience Research, 1994
- DNA deletion associated with hereditary neuropathy with liability to pressure palsiesCell, 1993
- Multiple molecular alterations in mouse lung tumorsMolecular Carcinogenesis, 1992
- DNA duplication associated with Charcot-Marie-Tooth disease type 1ACell, 1991